Company: CERO
Filing Date: 2025-02-07
Form Type: 424B3
Source: 0001213900-25-011071
Chunk: 263

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-02-07
Form: 424B3
Chunk 263
---
080 |     |               |     - |     | $        | 10.00 |     | 09/30/2034 |
| Andrew                                    
 “Al” Kucharchuk, Chief Financial Officer  |     | 10/01/2024 |     | 10/01/2024   |     |               |  1,250 |     |               | 3,750 |     | $        | 10.00 |     | 09/30/2034 |
| Kristen                                   
 Pierce, Chief Development Officer         |     | 10/01/2024 |     | 10/01/2024   |     |               |  1,784 |     |               |   875 |     | $        | 10.00 |     | 09/30/2034 |

Overview of Executive Compensation Program

Our Compensation Committee
anticipates annually reviewing the compensation of our employees, including our executive officers. In setting executive base salaries
and bonuses and granting equity incentive awards, the Compensation Committee considers compensation for comparable positions in the market,
the historical compensation levels of our executive officers, individual performance as compared to our expectations and objectives,
internal equity, our desire to motivate our employees to achieve short- and long-term results that are in the best interests of our stockholders,
and a long-term commitment to us. We intend to target a general competitive position and consider independent third-party benchmark analytics
to determine the mix of compensation of base salary, bonus and long-term incentives.

We engaged the services
of an external compensation consultant to advise on executive compensation matters including our overall compensation program design
and collection of market data to inform our compensation programs for our executive officers and members of our board of directors. The
compensation for our executive officers will have the following components: base salary, cash bonus opportunities, equity compensation,
employee benefits, and severance protections. Base salaries, employee benefits, and severance protections are designed to attract and
retain senior management talent. Annual cash bonuses and equity awards are used to promote performance-based pay that aligns the interests
of the named executive officers with the long-term interests of our stockholders and enhances executive retention.

Employment Arrangements

We are party to employment
agreements with each of our named executive officers. The arrangements generally provide for at-will employment without any specific
term and set forth the named executive officer’s initial base salary, bonus potential, eligibility for employee benefits and severance
benefits upon